Hepion Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
HEPA on Nasdaq, CTRVP on OTC
Industry
Pharmaceutical Preparations
Location
399 Thornall Street, First Floor, Edison, New Jersey

Insiders trading volume in the past year

Hepion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert T. Foster CEO and Director, Director $154K +$17.6K +12.9% Sep 18, 2023
Peter Wijngaard Director $29K +$32.2K Nov 24, 2023
M. Block Director Feb 19, 2024
Thomas Adams Director May 18, 2021
Gary Jacob Director Feb 19, 2024
Arnold Lippa Director May 18, 2021
John Brancaccio Chairman, Director Feb 19, 2024
Anand Reddi Director Jun 27, 2022
Michael J. Purcell Director Mar 6, 2024
Kaouthar Lbiati Director Feb 19, 2024
John Cavan Chief Financial Officer May 18, 2021

Recent Insider Transactions by Companies or Individuals for Hepion Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.